Company intelligence / Profile preview

GT Urological

Minneapolis, Minnesota, USApmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

GT Urological developed innovative medical devices to treat male stress urinary incontinence, including the ActiCuf Compression Pouch and an implantable artificial urinary sphincter. The company conducted multi-center clinical trials of its artificial sphincter device with endpoints focused on safety and efficacy. The ActiCuf was a disposable external compression pouch designed to manage urine flow by applying pressure to the urethra and capturing leaked urine. Their implantable TMOD (Tape Mechanical Occlusive Device) aimed to offer minimally invasive, adjustable continence control for men after prostate surgery[1][4][5][9].

Therapeutic areas: Men's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Contract Research Organization(s) for clinical trials

Beyond the preview

Go deeper on GT Urological.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GT Urological.

Explore the full profile